Mymd Pharmaceuticals (Florida), Inc.
Records under this name other than patents Mymd Pharmaceuticals (Florida), Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Mymd Pharmaceuticals (Florida), Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,884,055 | Method of treating substance addictions Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,471,052 | Method of treating addictions to opioids Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,517,856 | Methods of altering programmed cell death and extending cell life Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,588,899 | Methods of treating diabetes Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,722,506 | Method of treating multiple sclerosis Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,786,493 | Method of treating viral infections Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,806,728 | Pharmaceutical salts of isomyosmine and pharmaceutical compositions containing same Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,835,523 | Method of regulating tumor necrosis factor-alpha (TNF-α) for treating cancers, autoimmune disorders, and other disorders associated with chronic inflammation Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,918,633 | Method of treating coronavirus Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,096,933 | Method of treating disorders associated with chronic inflammation Formerly held In force · USPTO record | In force | USPTO record |